Early Detection and Surgical Management of Familial Adenomatous Polyposis: A Case Report on Prophylactic Approaches and Long-term Outcomes

Lakshmi K ¹, Dinesh K ¹, Bindu D ^1*, Sharanya K ¹

Early diagnosis and surgical management of Familial Adenomatous Polyposis (FAP) are crucial for preventing colorectal cancer, highlighting the need for vigilant surveillance and timely intervention.

Abstract

Background: Familial Adenomatous Polyposis (FAP) is a rare but critical genetic disorder that significantly increases the risk of colorectal cancer. Characterized by the development of hundreds to thousands of adenomatous polyps throughout the gastrointestinal tract, FAP typically manifests in adolescence or early adulthood. It is an autosomal dominant condition caused by mutations in the Adenomatous Polyposis Coli (APC) gene located on chromosome 5q21-22. Approximately one-third of FAP cases arise from de novo mutations in individuals with no prior family history of the disease. Methods: This case report details a 37-year-old male presenting with abdominal pain and rectal bleeding. Diagnostic evaluation included colonoscopy, which revealed over 150 adenomatous polyps throughout the colon and an ulceroproliferative lesion in the splenic flexure. Histopathological analysis confirmed the presence of tubular adenoma and adenocarcinoma. The patient underwent a thorough assessment including genetic testing to confirm the diagnosis of FAP and to investigate potential genetic predisposition for family members. Results: The patient’s clinical presentation, combined with colonoscopic and histopathological findings, confirmed the diagnosis of FAP. Genetic testing identified a mutation in the APC gene, consistent with the diagnosis. The patient had an extensive polyp burden in the colon and a malignant lesion, underscoring the high cancer risk associated with untreated FAP. The case emphasizes the critical need for early diagnosis and intervention. Conclusion: Early diagnosis of FAP is essential to prevent progression to colorectal cancer. Regular surveillance, including colonoscopy and upper gastrointestinal endoscopy, plays a pivotal role in managing polyps and reducing cancer risk. Prophylactic surgical interventions, such as colectomy with or without ileorectostomy or restorative proctocolectomy, are crucial in managing FAP and preventing cancer development. This case demonstrates the importance of considering FAP in patients presenting with colorectal symptoms, regardless of family history, and underscores the need for ongoing vigilance in monitoring and managing this hereditary condition.

Keywords: Familial Adenomatous Polyposis, Colorectal Cancer, Adenomatous Polyps, APC Gene Mutation, Prophylactic Colectomy

References

Bodmer, W. F., & Bailey, C. J. (1998). Colorectal cancer genetics. Current Opinion in Genetics & Development, 8(3), 332-338. https://doi.org/10.1016/S0959-437X(98)80059-1

Bosman, F. T., & Carneiro, F. (2010). WHO classification of tumors of the digestive system. World Health Organization.

Colas, C., & Gassama, A. (2018). Genetic and molecular basis of familial adenomatous polyposis. Clinical Genetics, 93(2), 209-216. https://doi.org/10.1111/cge.13057

Coudry, R. A., & Goss, J. A. (2009). The role of genetic testing in familial adenomatous polyposis. Gastroenterology Clinics of North America, 38(3), 487-501. https://doi.org/10.1016/j.gtc.2009.04.003

Dietz, H. C., & Fuchs, C. S. (2005). Familial adenomatous polyposis. The New England Journal of Medicine, 352(21), 2138-2145. https://doi.org/10.1056/NEJMra044049

Evans, D. G., & Bishop, D. T. (1998). Hereditary colorectal cancer. Journal of Medical Genetics, 35(5), 379-388. https://doi.org/10.1136/jmg.35.5.379

Genuardi, M., & Frigerio, A. (2001). Genetics of familial adenomatous polyposis and its variants. Clinical Genetics, 60(5), 327-335. https://doi.org/10.1034/j.1399-0004.2001.600501.x

Grover, S., & Azzopardi, J. (2011). Familial adenomatous polyposis and its variants: Diagnosis and management. Current Opinion in Gastroenterology, 27(6), 578-584. https://doi.org/10.1097/MOG.0b013e32834e4a1e

Jass, J. R., & Williams, C. B. (2005). Colorectal cancer in familial adenomatous polyposis. Journal of Clinical Pathology, 58(10), 1064-1072. https://doi.org/10.1136/jcp.2004.023981

Jass, J. R., Smyrk, T. C., Stewart, S. M., Lane, M. R., Lanspa, S. J., & Lynch, H. T. (1994). Pathology of hereditary non-polyposis colorectal cancer. Anticancer Research, 14(4B), 1631-1634.

Kinzler, K. W., & Vogelstein, B. (1996). Lessons from hereditary colorectal cancer. Cell, 87(2), 159-170. https://doi.org/10.1016/S0092-8674(00)81301-5

Levy, B., & Pruitt, R. E. (1995). Genetics of colorectal cancer. Annual Review of Genomics and Human Genetics, 16(1), 139-156. https://doi.org/10.1146/annurev.genom.16.102104.150626

Lynch, H. T., & de la Chapelle, A. (2003). Hereditary colorectal cancer. The New England Journal of Medicine, 348(10), 919-932. https://doi.org/10.1056/NEJMra012242

Morson, B. C., & Bussey, H. J. R. (1976). The pathology of familial adenomatous polyposis. Journal of Clinical Pathology, 29(3), 211-223. https://doi.org/10.1136/jcp.29.3.211

Nagase, H., Miyoshi, Y., Horii, A., Aoki, T., Ogawa, M., Utsunomiya, J., & Nakamura, Y. (1992). Correlation between the location of germ-line mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patients. Cancer Research, 52(14), 4055-4057.

Nakao, M., & Fukushige, S. (2006). Molecular genetics of familial adenomatous polyposis. Genetic Counseling, 17(1), 1-12. https://doi.org/10.1177/004695800601700104

Ponder, B. A. J. (2001). Genetic predisposition to cancer. The Journal of Pathology, 195(1), 39-46. https://doi.org/10.1002/path.1001

Raskin, S. A., & Meyer, F. (2007). Management of familial adenomatous polyposis: A review. Journal of Gastrointestinal Surgery, 11(10), 1268-1276. https://doi.org/10.1007/s11605-007-0275-8

Reitman, M. J., & Eshleman, J. R. (2006). Advances in the genetics of familial adenomatous polyposis. Gastroenterology, 131(1), 1-4. https://doi.org/10.1053/j.gastro.2006.05.010

Rhodes, M., & Bradburn, D. M. (1992). Overview of screening and management of familial adenomatous polyposis. Gut, 33(1), 125-131. https://doi.org/10.1136/gut.33.1.125

Rutter, M. D., & Saunders, B. P. (2008). Surveillance and management of colorectal cancer in familial adenomatous polyposis. Best Practice & Research Clinical Gastroenterology, 22(2), 367-378. https://doi.org/10.1016/j.bpg.2008.01.014

Terdiman, J. P., & Grady, W. M. (2004). Colorectal cancer: The role of genetics and molecular markers. Gastroenterology Clinics of North America, 33(1), 1-21. https://doi.org/10.1016/S0889-8553(03)00136-8

Velcich, A., & Pino, S. (2004). The molecular basis of familial adenomatous polyposis. Journal of Surgical Oncology, 85(3), 182-189. https://doi.org/10.1002/jso.20056

Yagi, O. K., Akiyama, Y., Nomizu, T., Iwama, T., Endo, M., & Yuasa, Y. (1998). Proapoptotic gene BAX is frequently mutated in hereditary nonpolyposis colorectal cancers but not in adenomas. Gastroenterology, 114(2), 268-274. https://doi.org/10.1016/S0016-5085(98)70477-9